Legal & General Group PLC Mirati Therapeutics, Inc. Transaction History

Legal & General Group PLC

$420 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$41.99 - $62.38 $165,482 - $245,839	-3,941 Reduced 8.39%	43,044 $2.53 Million
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $222,233 - $362,527	7,994 Added 20.5%	46,985 $2.05 Million
Q2 2023 Aug 14, 2023	SELL	$36.13 - $49.49 $44,945 - $61,565	-1,244 Reduced 3.09%	38,991 $1.41 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $185,477 - $275,423	5,076 Added 14.44%	40,235 $1.5 Million
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $45,231 - $108,087	-1,096 Reduced 3.02%	35,159 $1.59 Million

Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $127,449 - $185,711	-2,142 Reduced 5.58%	36,255 $2.53 Million
Q2 2022 Aug 22, 2022	SELL	$39.16 - $88.71 $11,513 - $26,080	-294 Reduced 0.76%	38,397 $2.58 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $178,404 - $355,232	2,353 Added 6.48%	38,691 $3.18 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $140,326 - $202,278	-1,063 Reduced 2.84%	36,338 $5.33 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $1.1 Million - $1.47 Million	8,306 Added 28.55%	37,401 $6.62 Million
Q2 2021 Aug 12, 2021	BUY	$144.0 - $179.73 $231,552 - $289,005	1,608 Added 5.85%	29,095 $4.7 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $81,684 - $113,907	-514 Reduced 1.84%	27,487 $4.71 Million
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $855,299 - $1.27 Million	5,278 Added 23.23%	28,001 $6.15 Million
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $566 - $836	-5 Reduced 0.02%	22,723 $3.77 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $92,028 - $153,858	1,278 Added 5.96%	22,728 $2.6 Million
Q1 2020 May 14, 2020	BUY	$69.78 - $116.21 $273,537 - $455,543	3,920 Added 22.36%	21,450 $1.65 Million
Q4 2019 Feb 13, 2020	BUY	$70.76 - $128.86 $75,500 - $137,493	1,067 Added 6.48%	17,530 $2.26 Million
Q3 2019 Nov 13, 2019	BUY	$77.91 - $109.6 $885,836 - $1.25 Million	11,370 Added 223.25%	16,463 $1.28 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $59,727 - $105,128	1,004 Added 24.55%	5,093 $525,000
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $19,817 - $35,843	454 Added 12.49%	4,089 $299,000
Q4 2018 Feb 15, 2019	BUY	$32.0 - $47.43 $16,480 - $24,426	515 Added 16.51%	3,635 $154,000
Q3 2018 Nov 20, 2018	BUY	$47.1 - $62.7 $3,673 - $4,890	78 Added 2.56%	3,120 $147,000
Q2 2018 Aug 10, 2018	BUY	$26.05 - $52.4 $79,244 - $159,400	3,042 New	3,042 $150,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account